| Ticker | RVMD |
|---|---|
| ISIN | US76155X1000 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhi...
El precio actual de Revolution Medicines, Inc. (RVMD) es de 135,30 , con una variación del 0,61%.
Revolution Medicines, Inc. opera en el sector Healthcare, industria Biotechnology.